Alpine Immune Sciences
ALPN
#3367
Rank
C$6.09 B
Marketcap
C$88.83
Share price
0.00%
Change (1 day)
433.30%
Change (1 year)

Earnings for Alpine Immune Sciences (ALPN)

Earnings in 2024 (TTM): -C$49.53 Million

According to Alpine Immune Sciences's latest financial reports the company's current earnings are C$56.52 Million. In 2023 the company made an earning of -C$43.87 Million, an increase over its 2022 earnings that were of -C$75.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alpine Immune Sciences from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$49.53 Million12.92%
2023 -C$43.87 Million-42.13%
2022 -C$75.79 Million9.94%
2021 -C$68.94 Million80.42%
2020 -C$38.21 Million-33.23%
2019 -C$57.23 Million13.56%
2018 -C$50.39 Million145.33%
2017 -C$20.54 Million-52.26%
2016 -C$43.02 Million37.89%
2015 -C$31.2 Million51.75%
2014 -C$20.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.21 Billion 302.97%๐Ÿ‡บ๐Ÿ‡ธ USA